Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Anti-fungal Drugs Market Status and Forecast (2017-2028)
  • 1.3.2 Global Anti-fungal Drugs Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Anti-fungal Drugs Supply by Company

• 2.1 Global Anti-fungal Drugs Sales Value by Company
• 2.2 Anti-fungal Drugs Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Anti-fungal Drugs Market Status by Type

• 3.1 Anti-fungal Drugs Type Introduction
  • 3.1.1 Powder
  • 3.1.2 Ointment
  • 3.1.3 Tablet
  • 3.1.4 Other
• 3.2 Global Anti-fungal Drugs Market by Type
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Anti-fungal Drugs Market Status by Application

• 4.1 Anti-fungal Drugs Segment by Application
  • 4.1.1 Hospital
  • 4.1.2 Retail Pharmacy
  • 4.1.3 Online Pharmacy
• 4.2 Global Anti-fungal Drugs Market by Application
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Anti-fungal Drugs Market Status by Region

• 5.1 Global Anti-fungal Drugs Market by Region
• 5.2 North America Anti-fungal Drugs Market Status
• 5.3 Europe Anti-fungal Drugs Market Status
• 5.4 Asia Pacific Anti-fungal Drugs Market Status
• 5.5 Central & South America Anti-fungal Drugs Market Status
• 5.6 Middle East & Africa Anti-fungal Drugs Market Status

6 North America Anti-fungal Drugs Market Status

• 6.1 North America Anti-fungal Drugs Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Anti-fungal Drugs Market Status

• 7.1 Europe Anti-fungal Drugs Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Anti-fungal Drugs Market Status

• 8.1 Asia Pacific Anti-fungal Drugs Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Anti-fungal Drugs Market Status

• 9.1 Central & South America Anti-fungal Drugs Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Anti-fungal Drugs Market Status

• 10.1 Middle East & Africa Anti-fungal Drugs Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Anti-fungal Drugs Market Forecast by Type and by Application

• 12.1 Global Anti-fungal Drugs Sales Value Forecast (2023-2028)
• 12.2 Global Anti-fungal Drugs Forecast by Type
• 12.3 Global Anti-fungal Drugs Forecast by Application

13 Global Anti-fungal Drugs Market Forecast by Region/Country

• 13.1 Global Anti-fungal Drugs Market Forecast by Region (2023-2028)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 SCYNEXIS
  • 14.1.1 Company Information
  • 14.1.2 Anti-fungal Drugs Product Introduction
  • 14.1.3 SCYNEXIS Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.1.4 SWOT Analysis
• 14.2 Sanofi
  • 14.2.1 Company Information
  • 14.2.2 Anti-fungal Drugs Product Introduction
  • 14.2.3 Sanofi Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.2.4 SWOT Analysis
• 14.3 Pfizer
  • 14.3.1 Company Information
  • 14.3.2 Anti-fungal Drugs Product Introduction
  • 14.3.3 Pfizer Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.3.4 SWOT Analysis
• 14.4 Novartis
  • 14.4.1 Company Information
  • 14.4.2 Anti-fungal Drugs Product Introduction
  • 14.4.3 Novartis Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.4.4 SWOT Analysis
• 14.5 Merck
  • 14.5.1 Company Information
  • 14.5.2 Anti-fungal Drugs Product Introduction
  • 14.5.3 Merck Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.5.4 SWOT Analysis
• 14.6 Kramer Laboratories
  • 14.6.1 Company Information
  • 14.6.2 Anti-fungal Drugs Product Introduction
  • 14.6.3 Kramer Laboratories Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.6.4 SWOT Analysis
• 14.7 Glenmark
  • 14.7.1 Company Information
  • 14.7.2 Anti-fungal Drugs Product Introduction
  • 14.7.3 Glenmark Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.7.4 SWOT Analysis
• 14.8 GlaxoSmithKline
  • 14.8.1 Company Information
  • 14.8.2 Anti-fungal Drugs Product Introduction
  • 14.8.3 GlaxoSmithKline Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.8.4 SWOT Analysis
• 14.9 Gilead Science
  • 14.9.1 Company Information
  • 14.9.2 Anti-fungal Drugs Product Introduction
  • 14.9.3 Gilead Science Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.9.4 SWOT Analysis
• 14.10 Enzon Pharmaceuticals
  • 14.10.1 Company Information
  • 14.10.2 Anti-fungal Drugs Product Introduction
  • 14.10.3 Enzon Pharmaceuticals Anti-fungal Drugs Sales Value, Gross Margin and Global Share (2020-2022)
  • 14.10.4 SWOT Analysis
• 14.11 Bayer
• 14.12 Astellas Pharma
• 14.13 Abbott Laboratories

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Anti-fungal Drugs market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Anti-fungal Drugs industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Anti-fungal Drugs market is estimated at $ 1730 million in 2021, and projected to grow at a CAGR of 2.8% to $ 2100 million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Anti-fungal Drugs Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Anti-fungal Drugs market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Anti-fungal Drugs Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Anti-fungal Drugs industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Powder
Ointment
Tablet
Other

Segmented by Application
Hospital
Retail Pharmacy
Online Pharmacy

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
SCYNEXIS
Sanofi
Pfizer
Novartis
Merck
Kramer Laboratories
Glenmark
GlaxoSmithKline
Gilead Science
Enzon Pharmaceuticals
Bayer
Astellas Pharma
Abbott Laboratories